Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021167
Company: NOVARTIS
Company: NOVARTIS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| VIVELLE | ESTRADIOL | 0.0375MG/24HR | FILM, EXTENDED RELEASE; TRANSDERMAL | Discontinued | None | No | No |
| VIVELLE | ESTRADIOL | 0.05MG/24HR | FILM, EXTENDED RELEASE; TRANSDERMAL | Prescription | None | No | No |
| VIVELLE | ESTRADIOL | 0.075MG/24HR | FILM, EXTENDED RELEASE; TRANSDERMAL | Discontinued | None | No | No |
| VIVELLE | ESTRADIOL | 0.1MG/24HR | FILM, EXTENDED RELEASE; TRANSDERMAL | Prescription | None | No | No |
| VIVELLE | ESTRADIOL | 0.025MG/24HR | FILM, EXTENDED RELEASE; TRANSDERMAL | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 08/16/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20323S23lbl.pdf |